Yvonne Wilding

Yvonne has over 20+ years leading strategic design and operational delivery of new medicines and novel drug delivery device projects. She has worked on more than 100 successful global pharma regulatory submissions – IND, CTA MAA, NDA, JNDA and PMTA in respiratory, cardiovascular, oncology immunology, and orphan drug indications, including small molecules, orphan drugs and biologicals. Yvonne has extensive experience designing and implementing change, releasing value and driving benefit realization within complex global organisations.